Cargando…

Liver fibrosis and adverse outcomes in COVID-19

Detalles Bibliográficos
Autor principal:	Huang, Jianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015429/ https://www.ncbi.nlm.nih.gov/pubmed/33994131 http://dx.doi.org/10.1016/j.dld.2021.03.024

Ejemplares similares

Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

The Associations Between Pharmacologic Gastric Acid Suppression and Adverse Outcomes in Patients With COVID-19
por: Dai, Cong, et al.
Publicado: (2021)

Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease
por: Kow, Chia Siang, et al.
Publicado: (2020)

Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis
por: Medina-De la Garza, Carlos Eduardo, et al.
Publicado: (2022)

Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease
por: Verma, Nipun, et al.
Publicado: (2021)

Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure
por: Zhang, Yiyan, et al.
Publicado: (2021)

Current ultrasound-related strategies for assessing liver fibrosis in chronic liver disease
por: Xue, Li-Yun, et al.
Publicado: (2020)

Reply to: “Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure”
por: Yousif, Walid Ibrahim
Publicado: (2021)

Lung fibrosis: an undervalued finding in COVID-19 pathological series
por: Grillo, Federica, et al.
Publicado: (2021)

The Effects of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Patients
por: Beşer, Ömer Faruk, et al.
Publicado: (2021)

Lung Fibrosis Following Acute Covid-19 Infection in an Infant
por: Rokaiyya, Anis, et al.
Publicado: (2022)

Comments on COVID-19 Vaccination and Exacerbation of Idiopathic Pulmonary Fibrosis
por: Kang, Tianlun, et al.
Publicado: (2022)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Clinical and immunological characteristics of vaccinated patients with COVID-19
por: Ping, Yu, et al.
Publicado: (2022)

Socioeconomic disparities in adverse birth outcomes in the Philippines
por: Lintao, Ryan C.V., et al.
Publicado: (2022)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
por: Chang, Kwok-Chiu, et al.
Publicado: (2021)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
por: Khouri, Charles, et al.
Publicado: (2021)

Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy
por: DeSilva, Malini, et al.
Publicado: (2022)

COVID-19 Among Liver Transplant Recipients
por: Moris, Dimitrios
Publicado: (2021)

COVID-19 and the liver: little cause for concern
por: Bangash, Mansoor N, et al.
Publicado: (2020)

Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
por: Campos-Murguía, Alejandro, et al.
Publicado: (2021)

Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care during the COVID-19 Pandemic
por: Ramos, Kathleen J., et al.
Publicado: (2020)

Myocardial fibrosis occurs in non-hospitalised patients with chronic symptoms after COVID-19
por: Krishnan, A., et al.
Publicado: (2022)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination – Authors' reply
por: Wong, Ian Chi Kei, et al.
Publicado: (2021)

Ultrasound-Enhancing Agents and Associated Adverse Reactions: A Potential Connection to the COVID-19 Vaccines?
por: Soni, Meshal, et al.
Publicado: (2022)

Histological analysis of hypoglycemic agents on liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review
por: Xie, Qingxing, et al.
Publicado: (2023)

Resuming liver transplantation amid the COVID-19 pandemic
por: Thorburn, Douglas, et al.
Publicado: (2021)

COVID-19 and liver transplantation: the jury is still out
por: Tavabie, Oliver D, et al.
Publicado: (2021)

Characteristics of Liver Transplant Patients Infected with COVID-19
por: Regmi, Parbatraj, et al.
Publicado: (2021)

Is Fibrosis Really Fibrosis?
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

Maladaptive TGF-β Signals to the Alveolar Epithelium Drive Fibrosis after COVID-19 Infection
por: Yao, Changfu, et al.
Publicado: (2023)

Utility of convolutional neural network-based algorithm in medical images for liver fibrosis assessment
por: Wei, Wei, et al.
Publicado: (2021)

Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells
por: Xuan, Yuanyuan, et al.
Publicado: (2022)

Safety and adverse events of urgent elective surgery during COVID-19 within three UK hospitals
por: Bertoncelli Tanaka, M, et al.
Publicado: (2020)

Novel Insight into Pulmonary Fibrosis and Long COVID
por: Kamp, Jan C., et al.
Publicado: (2023)

The many faces of coronavirus disease 2019: COVID-19 and the liver
por: Almas, Talal, et al.
Publicado: (2021)

COVID-19 and maternal and perinatal outcomes
por: Calvert, Clara, et al.
Publicado: (2021)

COVID-19 and maternal and perinatal outcomes
por: Ochoa, Lizbeth Burgos, et al.
Publicado: (2021)

COVID-19 and maternal and perinatal outcomes
por: Aranda, Zeus, et al.
Publicado: (2021)

No association of serum ferritin levels with advanced liver fibrosis in untreated German patients with autoimmune hepatitis
por: Engel, Bastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ue1gpa1oeermgd47l3233papkh